United-Guardian, Inc. (UG)
United-Guardian, Inc. (UG) is a diversified manufacturer of specialty personal care, health, and industrial products. Founded in 1946, the company develops and markets a range of proprietary formulations, including personal care products, pharmaceuticals, and industrial chemicals, serving clients worldwide. Known for its innovation and quality, United-Guardian focuses on niche markets with unique product offerings.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 1, 2025 | $0.25 | 2025-07-25 | 2025-07-25 |
| February 18, 2025 | $0.35 | 2025-02-10 | 2025-02-10 |
| July 31, 2024 | $0.35 | 2024-07-23 | 2024-07-23 |
| February 20, 2024 | $0.25 | 2024-02-09 | 2024-02-12 |
| August 2, 2023 | $0.10 | 2023-07-25 | 2023-07-26 |
Dividends Summary
- United-Guardian, Inc. has issued 46 dividend payments over the past 21 years
- The most recent dividend was paid 84 days ago, on August 1, 2025
- The highest dividend payed out to investors during this period was $0.65 per share
- The average dividend paid during this period was $0.37 per share.
Company News
United-Guardian reported a 16.3% revenue decline in Q2 2025, primarily due to weak cosmetic ingredient sales from distributor inventory issues. Medical lubricants and pharmaceutical products showed growth, with management hopeful for cosmetic sales recovery in the second half of the year.
United-Guardian, Inc. reported a 12% increase in net sales and a 26% increase in net income for fiscal year 2024 compared to 2023. The company saw strong growth in cosmetic ingredients and medical lubricants, but a supply disruption impacted pharmaceutical sales.
In our monthly Rare Stock Picks series, we're highlighting February 2024 investment picks. Click here for the list of February 2024 Buy recommendations.
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share. Ventyx Biosciences,...